ANXA6 and pancreatic ductal adenocarcinoma: ANXA6 enrichment in CAF-derived exosomes is reflected in the serum-derived exosomes of pancreatic ductal adenocarcinoma patients, where elevated ANXA6 levels are associated with higher tumor grades and poor clinical outcomes [90].